KOSÉ (4922) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Net sales rose 1.8% year-over-year to ¥78.9 billion, driven by strong ALBION performance in Japan and product development, offsetting declines in North America and other regions.
Operating profit fell 15.7% year-over-year to ¥6.6 billion due to a higher cost of sales ratio, increased SG&A expenses, inventory provisions, and costs from newly consolidated Puri.
Profit attributable to owners of parent dropped 23.8% year-over-year to ¥5.2 billion, impacted by foreign exchange losses and higher costs, despite a gain on sale of fixed assets.
Ordinary profit declined 49.8% to ¥5.2 billion, mainly from foreign exchange losses linked to yen appreciation.
Overseas sales accounted for 34.5% of total sales; comprehensive income declined 73.5% to ¥2.5 billion.
Financial highlights
Gross profit increased by ¥0.5 billion year-over-year to ¥56.6 billion, but the gross margin declined to 71.7% from 72.3%.
SG&A expenses rose 3.6% year-over-year, mainly from administrative costs and Puri consolidation.
Net income per share decreased to 92.75 yen from 121.69 yen year-over-year.
Capital expenditures increased to ¥10.6 billion, and depreciation rose to ¥2.9 billion.
Total assets at quarter-end were ¥377.3 billion, with an equity ratio of 71.7%.
Outlook and guidance
Full-year 2025 sales are forecast to grow 4.1% to ¥336.0 billion, with operating profit expected to rise 15.2% to ¥20.0 billion.
Net income attributable to owners of parent is projected to increase 83.7% to ¥13.8 billion, with EPS reaching 241.83 yen.
Japan sales are expected to see mid-single-digit growth, while Asia and North America/Europe/others are forecast for mid- to high-single-digit changes.
Management notes risks from global economic uncertainty, inflation, and trade friction, especially in China and the US.
Latest events from KOSÉ
- FY2025 delivered higher sales and profit, with FY2026 targeting further growth but lower net income.4922
Q4 202512 Feb 2026 - Sales up slightly, but profit down on higher costs and FX losses; full-year outlook maintained.4922
Q3 202510 Nov 2025 - Operating profit fell 17.7% as higher costs and FX losses offset modest sales growth.4922
Q2 20257 Aug 2025 - Double-digit profit growth led by Japan and North America, while China lags.4922
Q2 202413 Jun 2025 - Sales growth offset by China restructuring loss; profit outlook cut, dividend steady.4922
Q3 202413 Jun 2025 - 2024 profit fell on China reforms, but 2025 outlook is for strong recovery and sales growth.4922
Q4 20246 Jun 2025